< The University of Manchester Site
UMIC – University of Manchester Incubator Company
topborder
About UMIC
Graduates





IDEA EVALUATION PORTAL
Manchester Bioscience Incubator (MBI)
Core Technology Facility (CTF)
North Campus Incubator
One Central Park
Broadstone Knowledge Mill
Biotech Business Support
High Tech Business Support
Events
Jobs
Links
Contact Us
Intranet
video


Valid CSS!


HOME
ABOUT UMIC
INCUBATOR COMPANIES
PARTNERS&ASSOCIATES;
CONFERENCING
BIOTECH BUSINESS UNIT
HI TECH BUSINESS UNIT
E-NEWSLETTER
Incubator CompaniesCurrent TenantsGraduates


Graduates

HI-TECH

 

 

Thread

Thread – web design

Thread is an integrated agency with proven expertise and outstanding credentials in Strategy, Marketing and Technology. Using a mix of best practices and innovative thinking from each of these three areas, we work to improve your business success.

 

Loadsofoffers.com

Loadsofoffers.com – discounted e-vouchers

We offer discounted e-Vouchers direct to your mobile phone or downloaded to your computer ready to print out and use in many of the leading high street stores. All you need to do is register and start saving today on your purchases and at your regular high street store.

 

empty

BIOTECH

Intercytex

Intercytex – tissue regeneration

Intercytex is a healthcare company developing and commercialising innovative cell therapy products to restore and regenerate skin and hair. Intercytex is using its fully integrated proprietary cell therapy platform to develop products that harness the innate ability of human cells to regenerate and repair the body.

Syngenta

Syngenta – sustainable agriculture solutions

Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2006 were approximately $8.1 billion. Syngenta employs around 19,500 people in over 90 countries

Motac

Motac Neuroscience – brain function diagnostic development

Motac provides services to clients in the pharmaceutical and biotechnology industry to aid the discovery and development of diagnostics and therapeutics to treat disorders of higher brain function (eg movement disorders, Parkinson’s). These services include the progression of novel therapeutics through preclinical and clinical trials.

UK Biobank

UK Biobank – providing resources for medical researchers

UK Biobank is a long-term project aimed at building a comprehensive resource for medical researchers. The full project will get underway in 2006, when it will begin to gather information on the health and lifestyle of 500,000 volunteers aged between 40 and 69. Following consent, each participant will be asked to donate a blood and urine sample, have some standard measurements (such as blood pressure) and complete a confidential lifestyle questionnaire. Over the next 20 to 30 years UK Biobank will allow fully approved researchers to use these resources to study the progression of illnesses such as cancer, heart disease, diabetes and Alzheimer’s disease. From this they hope to develop new and better ways of preventing, diagnosing and treating such problems. Data and samples will only be used for ethically and scientifically approved research. Issues such as consent, confidentiality, and security of the data are guided by an Ethics and Governance Framework overseen by an independent council chaired by Professor Alastair V. Campbell of Bristol University.

UK Cord Blood Bank

Commercial Cord Blood Bank

The UK Cord Blood Bank (UKCBB) recevies and processes cord blood samples from throughout the UK, Europe and the Middle East, to support parents who have chosen to collect their baby’s stem cells for possible future use. As part of the world renowned New England Cryogenic Center which was founded in Boston USA in 1982, UKCBB was the first private cord blood bank in the UK and has provided cord blood processing and storage services to thousands of clients throughout Europe since 2000.

empty

Unsubscribe

Current News

Nano-Structured Materials in Tissue Engineering Focus Group Meeting

divider

New Business Support Scheme for Tenants

divider

£4m Innovation Vouchers Scheme launched

divider

31st BioNow Network Evening.

divider

Epistem to Present Plucked Hair Biomarker Data at ASCO-NCI-EORTC Meeting

divider

Arvia makes a splash

divider

BVCA Spin-Out Event 2008: Transformational growth in spin-out companies

divider

OFFICIAL OPENING OF STOCKPORT BUSINESS INCUBATOR

divider

Fire tornado to launch science festival programme – MOSI

divider

HOULDSWORTH KNOWLEDGE VILLAGE WINS TOP REGENERATION AWARD

divider

Epistem to present minimally invasive oncology biomarker data at AACR Meeting

divider

Manchester SME up against the big corporations

divider

Scientists in Schools

divider

Success for Houldsworth Knowledge Village

divider

Bionow R & D Tax Credits Event – Manchester & Liverpool Venues

divider

NWIN Biotech and Healthcare Networking Event

divider

EPISTEM AND ROTTAPHARM ANNOUNCE POSITIVE RESULTS

divider

Risk Awareness workshop – 18th Sept

divider

Regional Sector Networking Event: Biotech / Healthcare

divider

Welcome to UMIC\’s 2nd e-newsletter!

divider

Northwest business software provider launch online business TV channel

divider

F2G Ltd completes £6.3million financing round to fund preclinical and clinical development

divider

Bionow Network Evening – Tuesday 16 September 2008

divider

Knowledge village scheme on awards shortlist

divider

DxS Announces Appointment of Ron Long as Non-Executive Director

divider

Faculty of Engineering – N8 Centre for Translational Regenerative Medicine: Commercial Director (0.4 fte) wanted.

divider

The University of Manchester and GSK strike new research alliance

divider

Manchester gains funding for €170m Biobank.

divider

Darling meets spin-outs during Manchester visit

divider

Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests

divider

Manchester scientists highlighted for contribution to UK economy

divider

DxS Announces Plans to Expand its Manufacturing Capacity and Award of ISO 13485 certification

divider

TARGETED MOLECULAR DIAGNOSTICS and DxS ANNOUNCE A TIMELY WORKSHOP ON ASSESSING SOLID TUMOR MUTATIONS

divider

Welcome to UMIC’s first enewsletter!

divider

Stem cell hope for paralysed

divider

UMIC launches commercial drug discovery service for UK life sciences

divider

Mobysoft – SMS for Excellence

divider

Scientific workshop sets up at Broadstone Mill

divider

Illuminating Research – A bright future ahead as Nanoco sign a distribution agreement with Sigma-Aldrich

divider

DxS and Epigenomics AG enter Into Strategic Cross-Licensing Agreement for the Use of Scorpions® Technology

divider

Nanoco Technologies present a flagship example of the UK’s ability to transform world-class research into cutting edge business

divider

UMIP Spin-Out Gives Hope to Cancer Patients

divider

empty
Login to UMIC
 
   
Author
Author